SCHEMBL30315529

SCHEMBL30315529

CC(=O)NCC(C)CNc1nc(-c2cccnc2)nc2c1ncn2C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 15/20 0.50
▸ CCNB1 P14635 13/20 0.50
▸ CDK5 Q00535 7/20 0.50
▸ CDK5R1 Q15078 6/20 0.50
▸ CCNB2 O95067 5/20 0.50
▸ CCNB3 Q8WWL7 5/20 0.50
▸ CDK2 P24941 14/20 0.49
▸ CDK9 P50750 5/20 0.49
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ CDK4 P11802 10/20 0.45
▸ CDK7 P50613 10/20 0.45
▸ CCNE1 P24864 10/20 0.45
▸ MAPK1 P28482 9/20 0.45
▸ CCNH P51946 9/20 0.45
▸ CCND1 P24385 8/20 0.45
▸ CCNT1 O60563 3/20 0.45
▸ MNAT1 P51948 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312865 1.00 CDK1 (0.50) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL30315332 0.83 CDK5 (0.53) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2310970 0.83 CDK5 (0.53) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL21017207 0.82 CDK2 (0.52) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2315371 0.81 CDK2 (0.54) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL25308297 0.78 CCNK (0.64) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL30518535 0.78 CCNK (0.64) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL2318356 0.77 AHR (0.51) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL30518560 0.77 CDK2 (0.56) CDK1CCNB1CDK5CDK5R1CCNB2
SCHEMBL25309378 0.77 CDK2 (0.56) CDK1CCNB1CDK5CDK5R1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524604-B1 EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE NOVARTIS AG (CH) 2023-03-29 — — EP disclosed
Send feedback